Daniele Wikoff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Daniele Wikoff has a total of 168 co-authors. Here are the top co-authors by number of shared publications:
- Seneca Fitch
ToxStrategies, Katy, TX, USA
6 shared publications - Candace Doepker
ToxStrategies, LLC, East Fifth Street, Suite 1900 - #1353, Cincinnati, OH, 45202, United States
4 shared publications - William D. Klaren
ToxStrategies, LLC , Asheville, NC
4 shared publications - Caroline L. Ring
United States Environmental Protection Agency, Office of Research and Development, Center for Computational Toxicology and Exposure, 109 T.W. Alexander Drive, P.O. Box 12055, Research Triangle Park, 27709, NC, United States of America
3 shared publications - Charles P. O'BRien
Department of Psychiatry, University of Pennsylvania, Department of Behavior Health, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, United States
3 shared publications - Connie M. Weaver
School of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA, United States
3 shared publications
Latest Publications
- Open Access
- 21 January 2026
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 167, 106033
Smoke Flavoring-a case study demonstrating the value of using Benefit-risk analysis for foods (BRAFO) to provide transparency for risk management decisions
- 21 January 2026
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 167, 106033
Open AccessSmoke Flavoring-a case study demonstrating the value of using Benefit-risk analysis for foods (BRAFO) to provide transparency for risk management decisions
- Open Access
- 2 September 2025
- Published by Elsevier in Current Research in Toxicology
- Vol. 9
Approach for systematically assessing study reliability and relevance in evaluations of monosodium glutamate safety
- 2 September 2025
- Published by Elsevier in Current Research in Toxicology
- Vol. 9
Open AccessApproach for systematically assessing study reliability and relevance in evaluations of monosodium glutamate safety
- Open Access
- 5 August 2025
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 207 (2) , 289-305
Systematic review of potential developmental and reproductive toxicity of microplastics
Plastic microparticles, a form of microparticles commonly referred to as microplastics (MP), have been the focus of increasing interest for understanding potential human and ecological impacts, including the development of health-based benchmark values. This systematic review critically evaluates 24 mammalian studies reporting reproductive and developmental outcomes, a disproportionately focused research area, with a particular focus on methodological rigor and risk of bias. Fit-for-purpose aspects of selection, performance, and attrition bias were integrated into the critical appraisal to better understand the potential bias studies may have across these domains. All studies received a tier III rating based on the National Toxicology Program’s Office of Health Assessment and Translation framework, indicating a high risk of bias and insufficient reliability for risk assessment. Key issues identified across the body of evidence include poor exposure characterization, inadequate outcome assessment, lack of validated test guidelines, and failure to account for critical reproductive parameters such as estrous cycle monitoring and sperm analysis standards. Additionally, discrepancies in the particle characterization and homogeneity of the test material limit comparability and reproducibility across studies. This work highlights the current limitations in the body of evidence in terms of internal and construct validity, which preclude any conclusions on MP-related reproductive toxicity, and details a path forward for investigators to consider in future research.
- 5 August 2025
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 207 (2) , 289-305
Open AccessSystematic review of potential developmental and reproductive toxicity of microplastics
Plastic microparticles, a form of microparticles commonly referred to as microplastics (MP), have been the focus of increasing interest for understanding potential human and ecological impacts, including the development of health-based benchmark values. This systematic review critically evaluates 24 mammalian studies reporting reproductive and developmental outcomes, a disproportionately focused research area, with a particular focus on methodological rigor and risk of bias. Fit-for-purpose aspects of selection, performance, and attrition bias were integrated into the critical appraisal to better understand the potential bias studies may have across these domains. All studies received a tier III rating based on the National Toxicology Program’s Office of Health Assessment and Translation framework, indicating a high risk of bias and insufficient reliability for risk assessment. Key issues identified across the body of evidence include poor exposure characterization, inadequate outcome assessment, lack of validated test guidelines, and failure to account for critical reproductive parameters such as estrous cycle monitoring and sperm analysis standards. Additionally, discrepancies in the particle characterization and homogeneity of the test material limit comparability and reproducibility across studies. This work highlights the current limitations in the body of evidence in terms of internal and construct validity, which preclude any conclusions on MP-related reproductive toxicity, and details a path forward for investigators to consider in future research.
- Open Access
- 15 May 2025
- Published by Springer Nature in Archives of Toxicology
- Vol. 99 (7) , 3057-3063
How to organise a successful toxicology workshop? A participant perspective on the Collaboration to Harmonise the Assessment of Next Generation Evidence (CHANGE) workshop in Oslo, 18–20 June 2024
To create a regulatory infrastructure for the effective use of NAMs, the CHANGE project aims to organise three workshops to Collaborate and Harmonise the Assessment of Next Generation Evidence. To better ensure the success of the CHANGE approach, project organisers invited a group of participants to provide feedback on the first workshop held in Oslo on 18–20 June 2024. This report represents the participants’ perspective on the CHANGE working methodology and serves as a companion piece to the CHANGE organisers’ publication “Improving how we use workshops when solving complex research problems: Reflections from the CHANGE Project”, which provides a detailed description of the methodology, outputs, and conclusions from the workshop. The report includes feedback from most participants in response to the workshop evaluation as well as personal experiences from the authors. The workshop successfully facilitated stimulating engagement with a diversity of perspectives, though representation could be further broadened across sectors and geographies. Additionally, future workshops could refine the explanation of novel approaches to participants, as well as improve how information gathering is structured and formatted for feedback. Overall, participants were enthusiastic about CHANGE and believe the approach holds great promise in shaping future effective use of NAMs for chemical safety assessments. The report concludes with recommendations for follow-up workshops in 2025 and 2026, aiming to contribute to a regulatory infrastructure open to the acceptance and effective use of NAMs and to the use of similar workshops to address other emerging science policy issues.
- 15 May 2025
- Published by Springer Nature in Archives of Toxicology
- Vol. 99 (7) , 3057-3063
Open AccessHow to organise a successful toxicology workshop? A participant perspective on the Collaboration to Harmonise the Assessment of Next Generation Evidence (CHANGE) workshop in Oslo, 18–20 June 2024
To create a regulatory infrastructure for the effective use of NAMs, the CHANGE project aims to organise three workshops to Collaborate and Harmonise the Assessment of Next Generation Evidence. To better ensure the success of the CHANGE approach, project organisers invited a group of participants to provide feedback on the first workshop held in Oslo on 18–20 June 2024. This report represents the participants’ perspective on the CHANGE working methodology and serves as a companion piece to the CHANGE organisers’ publication “Improving how we use workshops when solving complex research problems: Reflections from the CHANGE Project”, which provides a detailed description of the methodology, outputs, and conclusions from the workshop. The report includes feedback from most participants in response to the workshop evaluation as well as personal experiences from the authors. The workshop successfully facilitated stimulating engagement with a diversity of perspectives, though representation could be further broadened across sectors and geographies. Additionally, future workshops could refine the explanation of novel approaches to participants, as well as improve how information gathering is structured and formatted for feedback. Overall, participants were enthusiastic about CHANGE and believe the approach holds great promise in shaping future effective use of NAMs for chemical safety assessments. The report concludes with recommendations for follow-up workshops in 2025 and 2026, aiming to contribute to a regulatory infrastructure open to the acceptance and effective use of NAMs and to the use of similar workshops to address other emerging science policy issues.
- Open Access
- 28 January 2025
- Published by Oxford University Press (OUP) in Environmental Toxicology and Chemistry
- Vol. 44 (4) , 1142-1153
An integrated ecotoxicological study reliability framework for use in toxicity value development
A key component of ecological risk assessments is to develop evidence-based benchmarks to assess potential hazards to various receptors. To ensure that toxicity value development is performed using the best available science, the reliability (or inherent scientific quality) of these studies must be considered. The degree of reliability can be evaluated via critical appraisal tools (CATs), though application of such methods assessing ecotoxicological literature for toxicity value development is not well established compared to human health assessments. A review of existing CATs revealed that there is currently no approach that considers the full range of biases that should be considered for appraisal of internal validity in ecotoxicological studies. Recognizing the need for a comprehensive ecotoxicity study assessment framework that addresses risk of bias (RoB) for the interpretation of study reliability, we propose the Ecotoxicological Study Reliability (EcoSR) framework. This framework builds upon the classic RoB assessment approach, frequently applied in human health assessments. EcoSR adds reliability and key criteria specific to ecotoxicity studies from existing appraisal methods, emphasizing those used by regulatory bodies. Additionally, the framework recommends a priori customization based on assessment goals. EcoSR is comprised of two tiers: an optional preliminary screening (Tier 1) and a full reliability assessment (Tier 2). The framework outlines a systematic approach for conducting ecotoxicity study appraisals that enhances transparency and consistency in determining study reliability. The EcoSR framework provides flexibility and can be refined and applied to a variety of chemical classes. This framework represents a significant step towards improving the transparency and reproducibility of ecotoxicological study appraisals; ultimately, contributing to more informed and reliable toxicity value development within the ecological sciences.
- 28 January 2025
- Published by Oxford University Press (OUP) in Environmental Toxicology and Chemistry
- Vol. 44 (4) , 1142-1153
Open AccessAn integrated ecotoxicological study reliability framework for use in toxicity value development
A key component of ecological risk assessments is to develop evidence-based benchmarks to assess potential hazards to various receptors. To ensure that toxicity value development is performed using the best available science, the reliability (or inherent scientific quality) of these studies must be considered. The degree of reliability can be evaluated via critical appraisal tools (CATs), though application of such methods assessing ecotoxicological literature for toxicity value development is not well established compared to human health assessments. A review of existing CATs revealed that there is currently no approach that considers the full range of biases that should be considered for appraisal of internal validity in ecotoxicological studies. Recognizing the need for a comprehensive ecotoxicity study assessment framework that addresses risk of bias (RoB) for the interpretation of study reliability, we propose the Ecotoxicological Study Reliability (EcoSR) framework. This framework builds upon the classic RoB assessment approach, frequently applied in human health assessments. EcoSR adds reliability and key criteria specific to ecotoxicity studies from existing appraisal methods, emphasizing those used by regulatory bodies. Additionally, the framework recommends a priori customization based on assessment goals. EcoSR is comprised of two tiers: an optional preliminary screening (Tier 1) and a full reliability assessment (Tier 2). The framework outlines a systematic approach for conducting ecotoxicity study appraisals that enhances transparency and consistency in determining study reliability. The EcoSR framework provides flexibility and can be refined and applied to a variety of chemical classes. This framework represents a significant step towards improving the transparency and reproducibility of ecotoxicological study appraisals; ultimately, contributing to more informed and reliable toxicity value development within the ecological sciences.
- 10 January 2025
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 204 (1) , 96-115
Application of a quantitative uncertainty assessment to develop ranges of plausible toxicity values when using observational data in risk assessment: a case study examining associations between PFOA and PFOS exposures and vaccine response
Traditional approaches for quantitatively characterizing uncertainty in risk assessment require adaptation to accommodate increased reliance on observational (vs experimental) studies in developing toxicity values. Herein, a case study with perfluorooctanoic acid (PFOA) and PFOS and vaccine response explores approaches for qualitative and—where possible—quantitative assessments of uncertainty at each step in the toxicity value development process when using observational data, including review and appraisal of individual studies, candidate study selection, dose–response modeling, and application of uncertainty factors. Each of the 15 studies identified had uncertainties due to risk of bias in confounding, outcome, and exposure ascertainment, likely contributing to the observed inconsistencies within and across studies, and resulting in lack of candidacy for dose–response assessment. Nonetheless, 2 representative studies were selected to demonstrate possible methods to quantify uncertainty in the remaining steps. Data simulations indicated lack of a clear dose–response relationship; dose–response models fit to representative simulations indicated high uncertainty in both the magnitude and direction of effect with simulated benchmark dose and its lower limit values varying at least 66- and 86-fold for PFOA and PFOS. Uncertainty factor application added minimal uncertainty. Combined, a high level of uncertainty was observed, precluding the ability to confidently assess causal dose–response relationships with the observational data, alone. This case study highlights the need for quantitative uncertainty analysis when developing toxicity values with observational data and, importantly, emphasizes the need for application of additional techniques to directly assess causality and the specificity of dose–response when relying on studies of association in quantitative risk assessment.
- 10 January 2025
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 204 (1) , 96-115
Application of a quantitative uncertainty assessment to develop ranges of plausible toxicity values when using observational data in risk assessment: a case study examining associations between PFOA and PFOS exposures and vaccine response
Traditional approaches for quantitatively characterizing uncertainty in risk assessment require adaptation to accommodate increased reliance on observational (vs experimental) studies in developing toxicity values. Herein, a case study with perfluorooctanoic acid (PFOA) and PFOS and vaccine response explores approaches for qualitative and—where possible—quantitative assessments of uncertainty at each step in the toxicity value development process when using observational data, including review and appraisal of individual studies, candidate study selection, dose–response modeling, and application of uncertainty factors. Each of the 15 studies identified had uncertainties due to risk of bias in confounding, outcome, and exposure ascertainment, likely contributing to the observed inconsistencies within and across studies, and resulting in lack of candidacy for dose–response assessment. Nonetheless, 2 representative studies were selected to demonstrate possible methods to quantify uncertainty in the remaining steps. Data simulations indicated lack of a clear dose–response relationship; dose–response models fit to representative simulations indicated high uncertainty in both the magnitude and direction of effect with simulated benchmark dose and its lower limit values varying at least 66- and 86-fold for PFOA and PFOS. Uncertainty factor application added minimal uncertainty. Combined, a high level of uncertainty was observed, precluding the ability to confidently assess causal dose–response relationships with the observational data, alone. This case study highlights the need for quantitative uncertainty analysis when developing toxicity values with observational data and, importantly, emphasizes the need for application of additional techniques to directly assess causality and the specificity of dose–response when relying on studies of association in quantitative risk assessment.
- Open Access
- 14 June 2024
- Published by Springer Nature in Archives of Toxicology
- Vol. 98 (8) , 2299-2308
Time for CHANGE: system-level interventions for bringing forward the date of effective use of NAMs in regulatory toxicology
- 14 June 2024
- Published by Springer Nature in Archives of Toxicology
- Vol. 98 (8) , 2299-2308
Open AccessTime for CHANGE: system-level interventions for bringing forward the date of effective use of NAMs in regulatory toxicology
- Open Access
- 28 March 2024
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 199 (2) , 172-193
Assessment of associations between inhaled formaldehyde and lymphohematopoietic cancer through the integration of epidemiological and toxicological evidence with biological plausibility
Formaldehyde is recognized as carcinogenic for portal of entry sites, though conclusions are mixed regarding lymphohematopoietic (LHP) cancers. This systematic review assesses the likelihood of a causal relationship between formaldehyde and LHP cancers by integrating components recommended by NASEM. Four experimental rodent bioassays and 16 observational studies in humans were included following implementation of the a priori protocol. All studies were assessed for risk of bias (RoB), and meta-analyses conducted on epidemiological studies, followed by a structured assessment of causation based on GRADE and Bradford Hill. RoB analysis identified systemic limitations precluding confidence in the epidemiological evidence due to inadequate characterization of formaldehyde exposure and a failure to adequately adjust for confounders or effect modifiers, thus suggesting that effect estimates are likely to be impacted by systemic bias. Mixed findings were reported in individual studies; meta-analyses did not identify significant associations between formaldehyde inhalation (when measured as ever/never exposure) and LHP outcomes, with meta-SMRs ranging from 0.50 to 1.51, depending on LHP subtype. No associations with LHP-related lesions were reported in reliable animal bioassays. No biologically plausible explanation linking inhalation of FA and LHP was identified, supported primarily by the lack of systemic distribution and in vivo genotoxicity. In conclusion, the inconsistent associations reported in a subset of the evidence were not considered causal when integrated with the totality of the epidemiological evidence, toxicological data, and considerations of biological plausibility. The impact of systemic biases identified herein could be quantitatively assessed to better inform causality and use in risk assessment.
- 28 March 2024
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 199 (2) , 172-193
Open AccessAssessment of associations between inhaled formaldehyde and lymphohematopoietic cancer through the integration of epidemiological and toxicological evidence with biological plausibility
Formaldehyde is recognized as carcinogenic for portal of entry sites, though conclusions are mixed regarding lymphohematopoietic (LHP) cancers. This systematic review assesses the likelihood of a causal relationship between formaldehyde and LHP cancers by integrating components recommended by NASEM. Four experimental rodent bioassays and 16 observational studies in humans were included following implementation of the a priori protocol. All studies were assessed for risk of bias (RoB), and meta-analyses conducted on epidemiological studies, followed by a structured assessment of causation based on GRADE and Bradford Hill. RoB analysis identified systemic limitations precluding confidence in the epidemiological evidence due to inadequate characterization of formaldehyde exposure and a failure to adequately adjust for confounders or effect modifiers, thus suggesting that effect estimates are likely to be impacted by systemic bias. Mixed findings were reported in individual studies; meta-analyses did not identify significant associations between formaldehyde inhalation (when measured as ever/never exposure) and LHP outcomes, with meta-SMRs ranging from 0.50 to 1.51, depending on LHP subtype. No associations with LHP-related lesions were reported in reliable animal bioassays. No biologically plausible explanation linking inhalation of FA and LHP was identified, supported primarily by the lack of systemic distribution and in vivo genotoxicity. In conclusion, the inconsistent associations reported in a subset of the evidence were not considered causal when integrated with the totality of the epidemiological evidence, toxicological data, and considerations of biological plausibility. The impact of systemic biases identified herein could be quantitatively assessed to better inform causality and use in risk assessment.
- 21 October 2023
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 145, 105500
Development and application of a systematic and quantitative weighting framework to evaluate the quality and relevance of relative potency estimates for dioxin-like compounds (DLCs) for human health risk assessment
- 21 October 2023
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 145, 105500
Development and application of a systematic and quantitative weighting framework to evaluate the quality and relevance of relative potency estimates for dioxin-like compounds (DLCs) for human health risk assessment